Hany S Ibrahim

11PUBLICATIONS
27CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsChemotherapyEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 02, 2026
Hybrids of Benzenesulfonamide Oxadiazole Derivatives with Dual CA II and COX-2 Inhibitory Activity Demonstrating Antiglaucoma and Anti-inflammatory Action: Synthesis, In Silico Insights, and In Vitro and In Vivo Bioevaluation.

|Nov 17, 2024
4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer Cells.

Wagdy M Eldehna, Mohamed Fares, Alessandro Bonardi

|Sep 18, 2024
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells.

Francesco Berluti, Fady Baselious, Sven Hagemann

|Apr 30, 2024
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors.

Dana M Odeh, Heba Abdelrasheed Allam, Fady Baselious

|Dec 09, 2023
Histone Acetyltransferase and Deacetylase Inhibitors-New Aspects and Developments.

Hany S Ibrahim, Wolfgang Sippl

|Nov 06, 2023
Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells.

Mohamed Abdelsalam, Mariia Zmyslia, Karin Schmidtkunz

Pageof 2

Frequent Collaborators

5 joint publications

Wolfgang Sippl

3 joint publications

Claudiu T Supuran

2 joint publications

Emre F Bülbül

2 joint publications

Fady Baselious